Inogen (INGN) Total Non-Current Liabilities (2013 - 2026)
Inogen (INGN) reported Total Non-Current Liabilities of $84.6 million for Q1 2026, down 23.38% year-over-year from $110.5 million in Q1 2025, and down 4.05% quarter-over-quarter from $88.2 million in Q4 2025.
Inogen (INGN) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Total Non-Current Liabilities data on file, last reported at $84.6 million in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $84.6 million, down 23.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $84.6 million (down 23.38% YoY), and the FY2025 annual result was $88.2 million, down 19.32% from the prior year.
- Total Non-Current Liabilities declined to $84.6 million in Q1 2026 per INGN's latest filing, from $88.2 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $113.1 million in Q1 2024 and troughed at $84.6 million in Q1 2026.
- A 5-year average of $102.1 million and a median of $108.9 million in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2026: Total Non-Current Liabilities climbed 26.64% in 2024, then slipped 23.38% in 2026.
- A 5-year view of Total Non-Current Liabilities shows it stood at $95.5 million in 2022, then grew by 16.62% to $111.4 million in 2023, then slipped by 1.85% to $109.3 million in 2024, then slipped by 19.32% to $88.2 million in 2025, then fell by 4.05% to $84.6 million in 2026.
- Business Quant data shows INGN's Total Non-Current Liabilities at $84.6 million in Q1 2026, $88.2 million in Q4 2025, and $92.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | 84.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.63 Mn |
| Dec 31, 2025 | 88.20 Mn |
| Sep 30, 2025 | 92.02 Mn |
| Jun 30, 2025 | 95.56 Mn |
| Mar 31, 2025 | 110.46 Mn |
| Dec 31, 2024 | 109.33 Mn |
| Sep 30, 2024 | 108.94 Mn |
| Jun 30, 2024 | 110.14 Mn |
| Mar 31, 2024 | 113.13 Mn |
| Dec 31, 2023 | 111.38 Mn |
| Sep 30, 2023 | 109.89 Mn |
| Jun 30, 2023 | 86.98 Mn |
| Mar 31, 2023 | 92.36 Mn |
| Dec 31, 2022 | 95.51 Mn |
| Sep 30, 2022 | 111.11 Mn |
| Jun 30, 2022 | 106.39 Mn |
| Mar 31, 2022 | 109.76 Mn |
| Dec 31, 2021 | 112.04 Mn |
| Sep 30, 2021 | 113.33 Mn |
| Jun 30, 2021 | 118.13 Mn |